163 related articles for article (PubMed ID: 1968955)
41. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
[TBL] [Abstract][Full Text] [Related]
42. Nutritional iron and dopamine binding sites in the rat brain.
Ashkenazi R; Ben-Shachar D; Youdim MB
Pharmacol Biochem Behav; 1982; 17 Suppl 1():43-7. PubMed ID: 7184034
[TBL] [Abstract][Full Text] [Related]
43. Down-regulation of haloperidol-induced striatal dopamine receptor supersensitivity by active analogues of L-prolyl-L-leucyl-glycinamide (PLG).
Rajakumar G; Naas F; Johnson RL; Chiu S; Yu KL; Mishra RK
Peptides; 1987; 8(5):855-61. PubMed ID: 2893360
[TBL] [Abstract][Full Text] [Related]
44. Neuroleptic drug-induced dopamine receptor supersensitivity: antagonism by L-prolyl-L-leucyl-glycinamide.
Chiu S; Paulose CS; Mishra RK
Science; 1981 Dec; 214(4526):1261-2. PubMed ID: 6117947
[TBL] [Abstract][Full Text] [Related]
45. Long-term adaptive changes in striatal dopamine function in response to chronic neuroleptic intake in rats.
Jenner P; Kerwin R; Rupniak NM; Murugaiah K; Hall MD; Fleminger S; Marsden CD
J Neural Transm Suppl; 1983; 18():205-12. PubMed ID: 6135741
[TBL] [Abstract][Full Text] [Related]
46. Repeated administration of sulpiride for three weeks produces behavioural and biochemical evidence for cerebral dopamine receptor supersensitivity.
Jenner P; Hall MD; Murugaiah K; Rupniak N; Theodorou A; Marsden CD
Biochem Pharmacol; 1982 Feb; 31(3):325-8. PubMed ID: 7200363
[TBL] [Abstract][Full Text] [Related]
47. Neuroleptics with differential affinities at dopamine D2 receptors and sigma receptors affect differently the N-methyl-D-aspartate-induced increase in intracellular calcium concentration: involvement of protein kinase.
Hayashi T; Su TP; Kagaya A; Nishida A; Shimizu M; Yamawaki S
Synapse; 1999 Jan; 31(1):20-8. PubMed ID: 10025680
[TBL] [Abstract][Full Text] [Related]
48. Lithium dissociates haloperidol-induced behavioral supersensitivity from reduced dopac increase in rat striatum.
Meller E; Friedman E
Eur J Pharmacol; 1981 Nov; 76(1):25-9. PubMed ID: 7318921
[TBL] [Abstract][Full Text] [Related]
49. Antipsychotic treatment leading to dopamine supersensitivity persistently alters nucleus accumbens function.
El Hage C; Bédard AM; Samaha AN
Neuropharmacology; 2015 Dec; 99():715-25. PubMed ID: 25823912
[TBL] [Abstract][Full Text] [Related]
50. Carbamazepine reduces dopamine-mediated behavior in chronic neuroleptic-treated and untreated rats: implications for treatment of tardive dyskinesia and hyperdopaminergic states.
LaHoste GJ; Wigal T; King BH; Schuck SEB; Crinella FM; Swanson JM
Exp Clin Psychopharmacol; 2000 Feb; 8(1):125-132. PubMed ID: 10743913
[TBL] [Abstract][Full Text] [Related]
51. In vitro and in vivo receptor binding and effects on monoamine turnover in rat brain regions of the novel antipsychotics risperidone and ocaperidone.
Leysen JE; Janssen PM; Gommeren W; Wynants J; Pauwels PJ; Janssen PA
Mol Pharmacol; 1992 Mar; 41(3):494-508. PubMed ID: 1372084
[TBL] [Abstract][Full Text] [Related]
52. Chronic neuroleptic treatment does not suppress the dynamic characteristics of the dopaminergic receptor D2 system.
Andia I; Zumarraga M; Retuerto F; Zamalloa I; Davila R
Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jan; 18(1):181-91. PubMed ID: 7906895
[TBL] [Abstract][Full Text] [Related]
53. Chronic treatment with clozapine, unlike haloperidol, does not induce changes in striatal D-2 receptor function in the rat.
Rupniak NM; Hall MD; Mann S; Fleminger S; Kilpatrick G; Jenner P; Marsden CD
Biochem Pharmacol; 1985 Aug; 34(15):2755-63. PubMed ID: 4040370
[TBL] [Abstract][Full Text] [Related]
54. Sigma opiates and certain antipsychotic drugs mutually inhibit (+)-[3H] SKF 10,047 and [3H]haloperidol binding in guinea pig brain membranes.
Tam SW; Cook L
Proc Natl Acad Sci U S A; 1984 Sep; 81(17):5618-21. PubMed ID: 6147851
[TBL] [Abstract][Full Text] [Related]
55. Effects of serotonergic agents on the up-regulation of dopamine D2 receptors induced by haloperidol in rat striatum.
Ishikane T; Kusumi I; Matsubara R; Matsubara S; Koyama T
Eur J Pharmacol; 1997 Feb; 321(2):163-9. PubMed ID: 9063684
[TBL] [Abstract][Full Text] [Related]
56. Upregulation of heat-shock protein HSP-70 and glutamate transporter-1/glutamine synthetase in the striatum and hippocampus in haloperidol-induced dopamine-supersensitivity-state rats.
Kimura M; Oda Y; Hirose Y; Kimura H; Yoshino K; Niitsu T; Kanahara N; Shirayama Y; Hashimoto K; Iyo M
Pharmacol Biochem Behav; 2021 Dec; 211():173288. PubMed ID: 34653399
[TBL] [Abstract][Full Text] [Related]
57. Comparative chronic effects of buspirone or neuroleptics on rat brain dopaminergic neurotransmission.
McMillen BA
J Neural Transm; 1985; 64(1):1-12. PubMed ID: 2866230
[TBL] [Abstract][Full Text] [Related]
58. Brain iron and dopamine receptor function.
Youdim MB; Ben-Shachar D; Ashkenazi R; Yehuda S
Adv Biochem Psychopharmacol; 1983; 37():309-21. PubMed ID: 6138953
[TBL] [Abstract][Full Text] [Related]
59. Behavioral and neurochemical responses to haloperidol and SCH-23390 in rats treated neonatally or as adults with 6-hydroxydopamine.
Duncan GE; Criswell HE; McCown TJ; Paul IA; Mueller RA; Breese GR
J Pharmacol Exp Ther; 1987 Dec; 243(3):1027-34. PubMed ID: 3121842
[TBL] [Abstract][Full Text] [Related]
60. Effects of haloperidol-induced dopamine receptor supersensitivity on kindled seizure development.
Gee KW; Killam EK; Hollinger MA
J Pharmacol Exp Ther; 1983 Apr; 225(1):70-6. PubMed ID: 6834278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]